EndoBarrier for counteracting obesity and metabolic syndrome;EndoBarrier tegen obesitas en het metabool syndroom

Nederlands Tijdschrift voor Geneeskunde

Volumn 156, Issue 13, 2012, Pages

  Verdam, Froukje J ^a   Liedorp, Paulien R ^a   Geubbels, Noëlle ^b   Schouten, Ruben ^a   Janssen, Ignace M C ^c   Koek, Ger H ^a   Greve, Jan Willem ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

^c RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIGESTIVE DEVICE; ENDOBARRIER; METABOLIC SYNDROME X; OBESITY; BARIATRIC SURGERY; DUODENUM; ENDOSCOPY; EQUIPMENT DESIGN; HUMAN; INSTRUMENTATION; JEJUNUM; METHODOLOGY; MORBID OBESITY; PHYSIOLOGY; WEIGHT REDUCTION;

BARIATRIC SURGERY; DUODENUM; ENDOSCOPY; EQUIPMENT DESIGN; HUMANS; JEJUNUM; METABOLIC SYNDROME X; OBESITY, MORBID; WEIGHT LOSS;

EID: 84873527190     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Schouten R, Rijs CS, Bouvy ND, et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2010;251:236-43.
2. Gersin KS, Rothstein RI, Rosenthal RJ, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc. 2010;71:976-82.
3. De Mouro EG, Orso IR, Martins BD, et al. Improvement of insulin resistance and reduction of cardiovascular risk among obese patients with type 2 diabetes with the duodenojejunal bypass liner. Obes Surg. 2011;21:941-7.
4. Escalona A, da Costa Martins B, Moura EGHD, et al. Endoscopic treatment of obesity and type 2 diabetes: Prospective study on the use of a temporary duodenal-jejunal exclusion device. Abstract. Bethesda: Digestive Disease Week; 2011.
5. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741-9.
6. De Jonge C, Verdam FJ, Rensen SS, et al. Endobarrier gastrointestinal liner rapidly improves diabetes parameters paralleled by increased postprandial GLP-1 and PYY levels in obese type 2 diabetic patients [abstract]. Haarlem: Nederlandse Vereniging Voor Gastroenterologie; 2010.